Detalhe da pesquisa
1.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res
; 26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297352
2.
Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer.
Breast Cancer Res Treat
; 197(2): 369-376, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409396
3.
Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches.
Ann Surg Oncol
; 30(10): 6141-6150, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466869
4.
A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.
Ann Surg
; 275(4): 784-792, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657941
5.
Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.
Ann Surg Oncol
; 28(4): 2146-2154, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946012
6.
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
Curr Treat Options Oncol
; 22(5): 38, 2021 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743085
7.
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.
Breast Cancer Res Treat
; 180(1): 207-217, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960171
8.
Surgery for Men with Breast Cancer: Do the Same Data Still Apply?
Ann Surg Oncol
; 27(12): 4720-4729, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32705510
9.
Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading.
Curr Treat Options Oncol
; 20(4): 35, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923913
10.
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).
Ann Surg
; 268(4): 591-601, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30048319
11.
ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer-Comparison of Approaches.
Ann Surg Oncol
; 30(10): 6151, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516728
12.
Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
Ann Surg Oncol
; 25(8): 2249-2260, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855830
13.
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal Perspective.
Clinicoecon Outcomes Res
; 16: 471-482, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38855430
14.
Clinical trials of self-replicating RNA-based cancer vaccines.
Cancer Gene Ther
; 30(6): 803-811, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765179
15.
The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective.
J Med Econ
; 26(1): 973-990, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466220
16.
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors.
EMBO Mol Med
; 15(10): e17367, 2023 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587872
17.
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
medRxiv
; 2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945501
18.
APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
Cancer Immunol Res
; 10(1): 70-86, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795033
19.
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
NPJ Breast Cancer
; 8(1): 134, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585404
20.
Mechanisms of Therapeutic Antitumor Monoclonal Antibodies.
Cancer Res
; 81(18): 4641-4651, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145037